Veratric acid ameliorates metabolic-dysfunction-associated fatty liver disease via targeting PPARG.
Metabolic dysfunction-associated fatty liver disease (MAFLD) is one of the most common metabolic syndromes worldwide. Its pathogenesis is multifactorial, involving disruptions in lipid metabolism, insulin resistance, chronic inflammation, and mitochondrial dysfunction. Veratric acid (VA), a naturally occurring phenolic...